{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T22:02:21Z","timestamp":1791928941068,"version":"4.3.4"},"reference-count":82,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Genome Ed."],"abstract":"<jats:p>Rett syndrome is an acquired progressive neurodevelopmental disorder caused by <jats:italic>de novo<\/jats:italic> mutations in the X-linked MECP2 gene which encodes a pleiotropic protein that functions as a global transcriptional regulator and a chromatin modifier. Rett syndrome predominantly affects heterozygous females while affected male hemizygotes rarely survive. Gene therapy of Rett syndrome has proven challenging due to a requirement for stringent regulation of expression with either over- or under-expression being toxic. Ectopic expression of MECP2 in conjunction with regulatory miRNA target sequences has achieved some success, but the durability of this approach remains unknown. Here we evaluated a nuclease-free homologous recombination (HR)-based genome editing strategy to correct mutations in the MECP2 gene. The stem cell-derived AAVHSCs have previously been shown to mediate seamless and precise HR-based genome editing. We tested the ability of HR-based genome editing to correct pathogenic mutations in Exons 3 and 4 of the MECP2 gene and restore the wild type sequence while preserving all native genomic regulatory elements associated with MECP2 expression, thus potentially addressing a significant issue in gene therapy for Rett syndrome. Moreover, since the mutations are edited directly at the level of the genome, the corrections are expected to be durable with progeny cells inheriting the edited gene. The AAVHSC MECP2 editing vector was designed to be fully homologous to the target MECP2 region and to insert a promoterless Venus reporter at the end of Exon 4. Evaluation of AAVHSC editing in a panel of Rett cell lines bearing mutations in Exons 3 and 4 demonstrated successful correction and rescue of expression of the edited MECP2 gene. Sequence analysis of edited Rett cells revealed successful and accurate correction of mutations in both Exons 3 and 4 and permitted mapping of HR crossover events. Successful correction was observed only when the mutations were flanked at both the 5\u2032 and 3\u2032 ends by crossover events, but not when both crossovers occurred either exclusively upstream or downstream of the mutation. Importantly, we concluded that pathogenic mutations were successfully corrected in every Rett line analyzed, demonstrating the therapeutic potential of HR-based genome editing.<\/jats:p>","DOI":"10.3389\/fgeed.2024.1346781","type":"journal-article","created":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T04:42:25Z","timestamp":1709268145000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":6,"title":["Nuclease-free precise genome editing corrects MECP2 mutations associated with Rett syndrome"],"prefix":"10.3389","volume":"6","author":[{"given":"Swati","family":"Bijlani","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ka Ming","family":"Pang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lakshmi V.","family":"Bugga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sampath","family":"Rangasamy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vinodh","family":"Narayanan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saswati","family":"Chatterjee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2024,3,1]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"440","DOI":"10.1136\/adc.2005.090290","article-title":"Cardiac disease and Rett syndrome","volume":"91","author":"Acampa","year":"2006","journal-title":"Arch. Dis. Child."},{"key":"B2","doi-asserted-by":"publisher","first-page":"E8","DOI":"10.1038\/s41586-018-0380-z","article-title":"Large deletions induced by Cas9 cleavage","volume":"560","author":"Adikusuma","year":"2018","journal-title":"Nature"},{"key":"B3","doi-asserted-by":"publisher","first-page":"4187","DOI":"10.1093\/hmg\/ddr346","article-title":"MeCP2 Rett mutations affect large scale chromatin organization","volume":"20","author":"Agarwal","year":"2011","journal-title":"Hum. Mol. Genet."},{"key":"B4","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1038\/13810","article-title":"Rett syndrome is caused by mutations in X-linked MECP2, encoding methyl-CpG-binding protein 2","volume":"23","author":"Amir","year":"1999","journal-title":"Nat. Genet."},{"key":"B5","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1186\/s13148-016-0214-5","article-title":"MeCP2 and the enigmatic organization of brain chromatin. Implications for depression and cocaine addiction","volume":"8","author":"Ausio","year":"2016","journal-title":"Clin. Epigenetics"},{"key":"B6","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1093\/brain\/awy323","article-title":"Towards a better diagnosis and treatment of Rett syndrome: a model synaptic disorder","volume":"142","author":"Banerjee","year":"2019","journal-title":"Brain"},{"key":"B7","doi-asserted-by":"publisher","first-page":"236","DOI":"10.3389\/fncel.2014.00236","article-title":"MeCP2 post-translational modifications: a mechanism to control its involvement in synaptic plasticity and homeostasis?","volume":"8","author":"Bellini","year":"2014","journal-title":"Front. Cell Neurosci."},{"key":"B8","doi-asserted-by":"publisher","first-page":"1169","DOI":"10.1093\/genetics\/161.3.1169","article-title":"Targeted chromosomal cleavage and mutagenesis in Drosophila using zinc-finger nucleases","volume":"161","author":"Bibikova","year":"2002","journal-title":"Genetics"},{"key":"B9","doi-asserted-by":"publisher","first-page":"799722","DOI":"10.3389\/fgeed.2021.799722","article-title":"The role of recombinant AAV in precise genome editing","volume":"3","author":"Bijlani","year":"2021","journal-title":"Front. Genome Ed."},{"key":"B10","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1083\/jcb.200502062","article-title":"Methyl CpG-binding proteins induce large-scale chromatin reorganization during terminal differentiation","volume":"169","author":"Brero","year":"2005","journal-title":"J. Cell Biol."},{"key":"B11","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1186\/s12881-020-0960-2","article-title":"Methyl-CpG-binding protein 2 (MECP2) mutation type is associated with bone disease severity in Rett syndrome","volume":"21","author":"Caffarelli","year":"2020","journal-title":"BMC Med. Genet."},{"key":"B12","doi-asserted-by":"publisher","first-page":"696","DOI":"10.1016\/j.molcel.2016.06.029","article-title":"Comprehensive identification of RNA-binding domains in human cells","volume":"63","author":"Castello","year":"2016","journal-title":"Mol. Cell"},{"key":"B13","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1016\/j.neuron.2007.10.001","article-title":"The story of Rett syndrome: from clinic to neurobiology","volume":"56","author":"Chahrour","year":"2007","journal-title":"Neuron"},{"key":"B14","doi-asserted-by":"publisher","first-page":"2223","DOI":"10.1002\/hep.31570","article-title":"Promoterless, nuclease-free genome editing confers a growth advantage for corrected hepatocytes in mice with methylmalonic acidemia","volume":"73","author":"Chandler","year":"2021","journal-title":"Hepatology"},{"key":"B15","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1006\/meth.1993.1007","article-title":"Adeno-associated viral vectors for the delivery of antisense RNA","volume":"5","author":"Chatterjee","year":"1993","journal-title":"Methods"},{"key":"B16","doi-asserted-by":"publisher","first-page":"1119","DOI":"10.1093\/hmg\/9.7.1119","article-title":"Long-read sequence analysis of the MECP2 gene in Rett syndrome patients: correlation of disease severity with mutation type and location","volume":"9","author":"Cheadle","year":"2000","journal-title":"Hum. Mol. Genet."},{"key":"B17","doi-asserted-by":"publisher","first-page":"e0233373","DOI":"10.1371\/journal.pone.0233373","article-title":"Molecular characterization of precise in vivo targeted gene integration in human cells using AAVHSC15","volume":"15","author":"Chen","year":"2020","journal-title":"PLoS One"},{"key":"B18","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1002\/ajmg.1320250540","article-title":"The genetics of Rett syndrome: the consequences of a disorder where every case is a new mutation","volume":"1","author":"Comings","year":"1986","journal-title":"Am. J. Med. Genet. Suppl."},{"key":"B19","doi-asserted-by":"publisher","first-page":"1231","DOI":"10.1038\/s41431-020-0624-x","article-title":"High rate of HDR in gene editing of p.(Thr158Met) MECP2 mutational hotspot","volume":"28","author":"Croci","year":"2020","journal-title":"Eur. J. Hum. Genet."},{"key":"B20","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1111\/jnc.15331","article-title":"MECP2 and the biology of MECP2 duplication syndrome","volume":"159","author":"D'Mello","year":"2021","journal-title":"J. Neurochem."},{"key":"B21","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1007\/BF01233363","article-title":"Sex difference in methylation of single-copy genes in human meiotic germ cells: implications for X chromosome inactivation, parental imprinting, and origin of CpG mutations","volume":"16","author":"Driscoll","year":"1990","journal-title":"Somat. Cell Mol. Genet."},{"key":"B22","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1186\/s13023-016-0545-5","article-title":"Rett syndrome - biological pathways leading from MECP2 to disorder phenotypes","volume":"11","author":"Ehrhart","year":"2016","journal-title":"Orphanet J. Rare Dis."},{"key":"B23","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1016\/j.neubiorev.2019.01.028","article-title":"Regression in Rett syndrome: developmental pathways to its onset","volume":"98","author":"Einspieler","year":"2019","journal-title":"Neurosci. Biobehav Rev."},{"key":"B24","doi-asserted-by":"publisher","first-page":"e0225582","DOI":"10.1371\/journal.pone.0225582","article-title":"Clade F AAVHSCs cross the blood brain barrier and transduce the central nervous system in addition to peripheral tissues following intravenous administration in nonhuman primates","volume":"14","author":"Ellsworth","year":"2019","journal-title":"PLoS One"},{"key":"B25","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1182\/blood.v88.2.492.bloodjournal882492","article-title":"Integration of adeno-associated virus vectors in CD34+ human hematopoietic progenitor cells after transduction","volume":"88","author":"Fisher-Adams","year":"1996","journal-title":"Blood"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1038\/s41587-023-01915-4","article-title":"Genotoxic effects of base and prime editing in human hematopoietic stem cells","author":"Fiumara","year":"2023","journal-title":"Nat. Biotechnol"},{"key":"B27","doi-asserted-by":"publisher","first-page":"822","DOI":"10.1038\/nbt.2623","article-title":"High-frequency off-target mutagenesis induced by CRISPR-Cas nucleases in human cells","volume":"31","author":"Fu","year":"2013","journal-title":"Nat. Biotechnol."},{"key":"B28","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1038\/mt.2012.200","article-title":"Improved survival and reduced phenotypic severity following AAV9\/MECP2 gene transfer to neonatal and juvenile male Mecp2 knockout mice","volume":"21","author":"Gadalla","year":"2013","journal-title":"Mol. Ther."},{"key":"B29","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1016\/j.omtm.2017.04.007","article-title":"Development of a novel AAV gene therapy cassette with improved safety features and efficacy in a mouse model of Rett syndrome","volume":"5","author":"Gadalla","year":"2017","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"B30","doi-asserted-by":"publisher","first-page":"13612","DOI":"10.1523\/JNEUROSCI.1854-13.2013","article-title":"Systemic delivery of MeCP2 rescues behavioral and cellular deficits in female mouse models of Rett syndrome","volume":"33","author":"Garg","year":"2013","journal-title":"J. Neurosci."},{"key":"B31","doi-asserted-by":"publisher","first-page":"2894","DOI":"10.1128\/MCB.06728-11","article-title":"Phosphorylation of distinct sites in MeCP2 modifies cofactor associations and the dynamics of transcriptional regulation","volume":"32","author":"Gonzales","year":"2012","journal-title":"Mol. Cell Biol."},{"key":"B32","doi-asserted-by":"publisher","first-page":"620859","DOI":"10.3389\/fgene.2021.620859","article-title":"MeCP2: the genetic driver of Rett syndrome epigenetics","volume":"12","author":"Good","year":"2021","journal-title":"Front. Genet."},{"key":"B33","doi-asserted-by":"publisher","first-page":"1143","DOI":"10.1126\/science.1138389","article-title":"Reversal of neurological defects in a mouse model of Rett syndrome","volume":"315","author":"Guy","year":"2007","journal-title":"Science"},{"key":"B34","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1111\/j.1651-2227.1985.tb10993.x","article-title":"Rett's syndrome: prevalence and impact on progressive severe mental retardation in girls","volume":"74","author":"Hagberg","year":"1985","journal-title":"Acta Paediatr. Scand."},{"key":"B35","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1016\/j.tig.2022.12.001","article-title":"Clinical progress in genome-editing technology and in vivo delivery techniques","volume":"39","author":"Khirallah","year":"2023","journal-title":"Trends Genet."},{"key":"B36","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1016\/j.mcn.2004.07.006","article-title":"MECP2 is progressively expressed in post-migratory neurons and is involved in neuronal maturation rather than cell fate decisions","volume":"27","author":"Kishi","year":"2004","journal-title":"Mol. Cell Neurosci."},{"key":"B37","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1016\/j.molcel.2005.07.021","article-title":"DNA binding selectivity of MeCP2 due to a requirement for A\/T sequences adjacent to methyl-CpG","volume":"19","author":"Klose","year":"2005","journal-title":"Mol. Cell"},{"key":"B38","doi-asserted-by":"publisher","first-page":"765","DOI":"10.1038\/nbt.4192","article-title":"Repair of double-strand breaks induced by CRISPR-Cas9 leads to large deletions and complex rearrangements","volume":"36","author":"Kosicki","year":"2018","journal-title":"Nat. Biotechnol."},{"key":"B39","doi-asserted-by":"publisher","first-page":"922","DOI":"10.1002\/humu.23263","article-title":"RettBASE: Rett syndrome database update","volume":"38","author":"Krishnaraj","year":"2017","journal-title":"Hum. Mutat."},{"key":"B40","doi-asserted-by":"publisher","first-page":"E3243","DOI":"10.1073\/pnas.1700731114","article-title":"Structure of the MeCP2-TBLR1 complex reveals a molecular basis for Rett syndrome and related disorders","volume":"114","author":"Kruusvee","year":"2017","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"B41","doi-asserted-by":"publisher","first-page":"6357","DOI":"10.1021\/acs.biochem.5b00790","article-title":"Impact of Rett syndrome mutations on MeCP2 MBD stability","volume":"54","author":"Kucukkal","year":"2015","journal-title":"Biochemistry"},{"key":"B42","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1038\/nbt.2916","article-title":"Genome-wide analysis reveals characteristics of off-target sites bound by the Cas9 endonuclease","volume":"32","author":"Kuscu","year":"2014","journal-title":"Nat. Biotechnol."},{"key":"B43","doi-asserted-by":"publisher","first-page":"3029","DOI":"10.1093\/hmg\/ddw156","article-title":"MeCP2 co-ordinates liver lipid metabolism with the NCoR1\/HDAC3 corepressor complex","volume":"25","author":"Kyle","year":"2016","journal-title":"Hum. Mol. Genet."},{"key":"B44","doi-asserted-by":"publisher","first-page":"625","DOI":"10.3389\/fgene.2019.00625","article-title":"Efficient and precise CRISPR\/Cas9-Mediated MECP2 modifications in human-induced pluripotent stem cells","volume":"10","author":"Le","year":"2019","journal-title":"Front. Genet."},{"key":"B45","doi-asserted-by":"publisher","first-page":"440","DOI":"10.1038\/s41586-020-2574-4","article-title":"MeCP2 links heterochromatin condensates and neurodevelopmental disease","volume":"586","author":"Li","year":"2020","journal-title":"Nature"},{"key":"B46","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1042\/BSR20100124","article-title":"A brain-derived MeCP2 complex supports a role for MeCP2 in RNA processing","volume":"31","author":"Long","year":"2011","journal-title":"Biosci. Rep."},{"key":"B47","doi-asserted-by":"publisher","first-page":"e52629","DOI":"10.7554\/eLife.52629","article-title":"Whole brain delivery of an instability-prone Mecp2 transgene improves behavioral and molecular pathological defects in mouse models of Rett syndrome","volume":"9","author":"Luoni","year":"2020","journal-title":"Elife"},{"key":"B48","doi-asserted-by":"publisher","first-page":"430","DOI":"10.1038\/mt.2016.10","article-title":"Genome-editing technologies for gene and cell therapy","volume":"24","author":"Maeder","year":"2016","journal-title":"Mol. Ther."},{"key":"B49","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1186\/s13072-019-0298-1","article-title":"MeCP2-E1 isoform is a dynamically expressed, weakly DNA-bound protein with different protein and DNA interactions compared to MeCP2-E2","volume":"12","author":"Martinez de Paz","year":"2019","journal-title":"Epigenetics Chromatin"},{"key":"B50","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.nbd.2016.12.009","article-title":"A codon-optimized Mecp2 transgene corrects breathing deficits and improves survival in a mouse model of Rett syndrome","volume":"99","author":"Matagne","year":"2017","journal-title":"Neurobiol. Dis."},{"key":"B51","doi-asserted-by":"publisher","first-page":"9057","DOI":"10.1007\/s12035-018-1046-4","article-title":"Elevated MeCP2 in mice causes neurodegeneration involving tau dysregulation and excitotoxicity: implications for the understanding and treatment of MeCP2 triplication syndrome","volume":"55","author":"Montgomery","year":"2018","journal-title":"Mol. Neurobiol."},{"key":"B52","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1016\/s0092-8674(00)81887-5","article-title":"MeCP2 is a transcriptional repressor with abundant binding sites in genomic chromatin","volume":"88","author":"Nan","year":"1997","journal-title":"Cell"},{"key":"B53","doi-asserted-by":"publisher","first-page":"2709","DOI":"10.1073\/pnas.0608056104","article-title":"Interaction between chromatin proteins MECP2 and ATRX is disrupted by mutations that cause inherited mental retardation","volume":"104","author":"Nan","year":"2007","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"B54","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1002\/ajmg.b.32707","article-title":"The array of clinical phenotypes of males with mutations in Methyl-CpG binding protein 2","volume":"180","author":"Neul","year":"2019","journal-title":"Am. J. Med. Genet. B Neuropsychiatr. Genet."},{"key":"B55","doi-asserted-by":"publisher","first-page":"864","DOI":"10.1128\/MCB.01593-06","article-title":"Multiple modes of interaction between the methylated DNA binding protein MeCP2 and chromatin","volume":"27","author":"Nikitina","year":"2007","journal-title":"Mol. Cell Biol."},{"key":"B56","doi-asserted-by":"publisher","first-page":"839","DOI":"10.1038\/nbt.2673","article-title":"High-throughput profiling of off-target DNA cleavage reveals RNA-programmed Cas9 nuclease specificity","volume":"31","author":"Pattanayak","year":"2013","journal-title":"Nat. Biotechnol."},{"key":"B57","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1186\/s13643-023-02169-6","article-title":"Global prevalence of Rett syndrome: systematic review and meta-analysis","volume":"12","author":"Petriti","year":"2023","journal-title":"Syst. Rev."},{"key":"B58","doi-asserted-by":"publisher","DOI":"10.1101\/2023.08.22.554338","article-title":"Genome-wide assays to characterize rAAV integration into human genomic DNA in vivo","author":"Prout","year":"2023","journal-title":"bioRxiv"},{"key":"B59","volume-title":"Molecular cloning: a laboratory manual","author":"Sambrook","year":"1989"},{"key":"B60","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1111\/j.1399-0004.2008.01005.x","article-title":"Severe congenital encephalopathy caused by MECP2 null mutations in males: central hypoxia and reduced neuronal dendritic structure","volume":"74","author":"Schule","year":"2008","journal-title":"Clin. Genet."},{"key":"B61","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1186\/s13073-017-0411-7","article-title":"MeCP2 mutations: progress towards understanding and treating Rett syndrome","volume":"9","author":"Shah","year":"2017","journal-title":"Genome Med."},{"key":"B62","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1093\/hmg\/11.2.115","article-title":"Insight into Rett syndrome: MeCP2 levels display tissue- and cell-specific differences and correlate with neuronal maturation","volume":"11","author":"Shahbazian","year":"2002","journal-title":"Hum. Mol. Genet."},{"key":"B63","doi-asserted-by":"publisher","first-page":"1259","DOI":"10.1086\/345360","article-title":"Rett syndrome and MeCP2: linking epigenetics and neuronal function","volume":"71","author":"Shahbazian","year":"2002","journal-title":"Am. J. Hum. Genet."},{"key":"B64","doi-asserted-by":"publisher","first-page":"624290","DOI":"10.3389\/fgene.2021.624290","article-title":"The molecular functions of MeCP2 in Rett syndrome pathology","volume":"12","author":"Sharifi","year":"2021","journal-title":"Front. Genet."},{"key":"B65","doi-asserted-by":"publisher","first-page":"4132","DOI":"10.1093\/hmg\/ddx300","article-title":"MeCP2_E1 N-terminal modifications affect its degradation rate and are disrupted by the Ala2Val Rett mutation","volume":"26","author":"Sheikh","year":"2017","journal-title":"Hum. Mol. Genet."},{"key":"B66","doi-asserted-by":"publisher","first-page":"3005","DOI":"10.1093\/brain\/awab182","article-title":"Engineered microRNA-based regulatory element permits safe high-dose miniMECP2 gene therapy in Rett mice","volume":"144","author":"Sinnett","year":"2021","journal-title":"Brain"},{"key":"B67","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1016\/j.omtm.2017.04.006","article-title":"Improved MECP2 gene therapy extends the survival of MeCP2-null mice without apparent toxicity after intracisternal delivery","volume":"5","author":"Sinnett","year":"2017","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"B68","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1016\/j.molcel.2010.01.030","article-title":"Neuronal MeCP2 is expressed at near histone-octamer levels and globally alters the chromatin state","volume":"37","author":"Skene","year":"2010","journal-title":"Mol. Cell"},{"key":"B69","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1016\/j.omtm.2022.06.013","article-title":"Natural variations in AAVHSC16 significantly reduce liver tropism and maintain broad distribution to periphery and CNS","volume":"26","author":"Smith","year":"2022","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"B70","doi-asserted-by":"publisher","first-page":"E7379","DOI":"10.1073\/pnas.1802343115","article-title":"Stem cell-derived clade F AAVs mediate high-efficiency homologous recombination-based genome editing","volume":"115","author":"Smith","year":"2018","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"B71","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/j.gendis.2018.09.005","article-title":"Structural investigation of rett-inducing MeCP2 mutations","volume":"6","author":"Spiga","year":"2019","journal-title":"Genes Dis."},{"key":"B72","doi-asserted-by":"publisher","first-page":"3567","DOI":"10.1523\/JNEUROSCI.1829-22.2023","article-title":"Single systemic administration of a gene therapy leading to disease treatment in metachromatic leukodystrophy arsa knock-out mice","volume":"43","author":"St Martin","year":"2023","journal-title":"J. Neurosci."},{"key":"B73","doi-asserted-by":"publisher","first-page":"1607","DOI":"10.1038\/nn.2959","article-title":"5-hmC-mediated epigenetic dynamics during postnatal neurodevelopment and aging","volume":"14","author":"Szulwach","year":"2011","journal-title":"Nat. Neurosci."},{"key":"B74","doi-asserted-by":"publisher","first-page":"398","DOI":"10.1038\/nature24058","article-title":"Radically truncated MeCP2 rescues Rett syndrome-like neurological defects","volume":"550","author":"Tillotson","year":"2017","journal-title":"Nature"},{"key":"B75","doi-asserted-by":"publisher","first-page":"1093","DOI":"10.1086\/320109","article-title":"MECP2 mutations in sporadic cases of Rett syndrome are almost exclusively of paternal origin","volume":"68","author":"Trappe","year":"2001","journal-title":"Am. J. Hum. Genet."},{"key":"B76","doi-asserted-by":"publisher","first-page":"4567","DOI":"10.1016\/j.cell.2023.08.041","article-title":"Mitigation of chromosome loss in clinical CRISPR-Cas9-engineered T cells","volume":"186","author":"Tsuchida","year":"2023","journal-title":"Cell"},{"key":"B77","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1007\/s00335-019-09793-5","article-title":"Treating Rett syndrome: from mouse models to human therapies","volume":"30","author":"Vashi","year":"2019","journal-title":"Mamm. Genome"},{"key":"B78","doi-asserted-by":"publisher","first-page":"997","DOI":"10.1161\/CIRCRESAHA.113.301702","article-title":"MicroRNA-mediated epigenetic silencing of sirtuin1 contributes to impaired angiogenic responses","volume":"113","author":"Volkmann","year":"2013","journal-title":"Circ. Res."},{"key":"B79","doi-asserted-by":"publisher","first-page":"eadd8643","DOI":"10.1126\/science.add8643","article-title":"CRISPR technology: a decade of genome editing is only the beginning","volume":"379","author":"Wang","year":"2023","journal-title":"Science"},{"key":"B80","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1038\/s41422-020-0288-7","article-title":"Rett syndrome-causing mutations compromise MeCP2-mediated liquid-liquid phase separation of chromatin","volume":"30","author":"Wang","year":"2020","journal-title":"Cell Res."},{"key":"B81","doi-asserted-by":"publisher","first-page":"2706","DOI":"10.1021\/acschembio.6b00450","article-title":"Binding analysis of methyl-CpG binding domain of MeCP2 and Rett syndrome mutations","volume":"11","author":"Yang","year":"2016","journal-title":"ACS Chem. Biol."},{"key":"B82","doi-asserted-by":"publisher","first-page":"17551","DOI":"10.1073\/pnas.0507856102","article-title":"Regulation of RNA splicing by the methylation-dependent transcriptional repressor methyl-CpG binding protein 2","volume":"102","author":"Young","year":"2005","journal-title":"Proc. Natl. Acad. Sci. U. S. A."}],"container-title":["Frontiers in Genome Editing"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fgeed.2024.1346781\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T04:42:29Z","timestamp":1709268149000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fgeed.2024.1346781\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3,1]]},"references-count":82,"alternative-id":["10.3389\/fgeed.2024.1346781"],"URL":"https:\/\/doi.org\/10.3389\/fgeed.2024.1346781","relation":{},"ISSN":["2673-3439"],"issn-type":[{"value":"2673-3439","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,3,1]]},"article-number":"1346781"}}